News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,838 Results
Type
Article (40011)
Company Profile (250)
Press Release (664576)
Multimedia
Podcasts (59)
Webinars (14)
Section
Business (204276)
Career Advice (2011)
Deals (35453)
Drug Delivery (95)
Drug Development (81140)
Employer Resources (172)
FDA (16249)
Job Trends (14887)
News (345501)
Policy (32606)
Tag
Academia (2556)
Accelerated approval (9)
Adcomms (22)
Allergies (95)
Alliances (49569)
ALS (108)
Alzheimer's disease (1441)
Antibody-drug conjugate (ADC) (151)
Approvals (16245)
Artificial intelligence (308)
Autoimmune disease (28)
Automation (18)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (121)
Biotechnology (175)
Bladder cancer (93)
Brain cancer (33)
Breast cancer (365)
Cancer (2858)
Cardiovascular disease (212)
Career advice (1681)
Career pathing (30)
CAR-T (185)
CDC (30)
Cell therapy (497)
Cervical cancer (22)
Clinical research (66849)
Collaboration (1011)
Company closure (3)
Compensation (686)
Complete response letters (22)
COVID-19 (2624)
CRISPR (56)
C-suite (324)
Cystic fibrosis (112)
Data (2991)
Decentralized trials (2)
Denatured (20)
Depression (60)
Diabetes (346)
Diagnostics (6423)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (137)
Drug pricing (121)
Drug shortages (28)
Duchenne muscular dystrophy (124)
Earnings (87450)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (113738)
Executive appointments (845)
FDA (17894)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (928)
Gene editing (129)
Generative AI (22)
Gene therapy (372)
GLP-1 (780)
Government (4501)
Grass and pollen (4)
Guidances (181)
Healthcare (18839)
HIV (40)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (146)
Immuno-oncology (8)
Indications (39)
Infectious disease (2796)
Inflammatory bowel disease (148)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (119)
Interviews (312)
IPO (16591)
IRA (44)
Job creations (3637)
Job search strategy (1424)
Kidney cancer (13)
Labor market (52)
Layoffs (492)
Leadership (18)
Legal (7929)
Liver cancer (79)
Longevity (11)
Lung cancer (399)
Lymphoma (208)
Machine learning (11)
Management (58)
Manufacturing (383)
MASH (90)
Medical device (13462)
Medtech (13467)
Mergers & acquisitions (19577)
Metabolic disorders (847)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (113)
Neuropsychiatric disorders (32)
Neuroscience (2116)
NextGen: Class of 2025 (6517)
Non-profit (4488)
Now hiring (47)
Obesity (427)
Opinion (217)
Ovarian cancer (101)
Pain (105)
Pancreatic cancer (120)
Parkinson's disease (186)
Partnered (22)
Patents (296)
Patient recruitment (163)
Peanut (50)
People (57684)
Pharmaceutical (63)
Pharmacy benefit managers (21)
Phase I (20827)
Phase II (29445)
Phase III (21916)
Pipeline (1626)
Policy (199)
Postmarket research (2563)
Preclinical (8870)
Press Release (64)
Prostate cancer (140)
Psychedelics (36)
Radiopharmaceuticals (253)
Rare diseases (457)
Real estate (5917)
Recruiting (66)
Regulatory (22625)
Reports (50)
Research institute (2326)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (156)
Series B (108)
Service/supplier (11)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3587)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (57)
The Weekly (37)
Vaccines (778)
Venture capital (53)
Weight loss (256)
Women's health (47)
Worklife (16)
Date
Today (66)
Last 7 days (361)
Last 30 days (1884)
Last 365 days (31204)
2025 (16732)
2024 (35219)
2023 (40077)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32110)
2016 (31480)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (720)
Alabama (61)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (38203)
Australia (6232)
California (7430)
Canada (2357)
China (669)
Colorado (320)
Connecticut (318)
Delaware (192)
Europe (82101)
Florida (1116)
Georgia (247)
Hawaii (1)
Idaho (59)
Illinois (636)
India (26)
Indiana (361)
Iowa (16)
Japan (227)
Kansas (108)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1020)
Massachusetts (5518)
Michigan (246)
Minnesota (449)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (80)
New Hampshire (66)
New Jersey (2070)
New Mexico (28)
New York (2082)
North Carolina (1079)
North Dakota (8)
Northern California (3272)
Ohio (235)
Oklahoma (16)
Oregon (34)
Pennsylvania (1610)
Puerto Rico (17)
Rhode Island (36)
South America (1098)
South Carolina (34)
South Dakota (1)
Southern California (2778)
Tennessee (126)
Texas (1122)
United States (27523)
Utah (219)
Virginia (184)
Washington D.C. (72)
Washington State (631)
West Virginia (4)
Wisconsin (66)
704,838 Results for "endologix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Endologix Appoints Graham Phillips as Chief Operating Officer
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce the appointment of Graham Phillips as its new Chief Operating Officer, effective immediately.
June 18, 2024
·
3 min read
Business
Endologix Announces that Art Taylor Joins Board of Directors
Endologix LLC is pleased to announce that Art Taylor has been appointed to the Endologix Board of Directors.
January 25, 2024
·
2 min read
Business
Endologix Announces that Scott Ward Joins Board of Directors
Endologix LLC is pleased to announce that Scott Ward has been appointed to the Endologix Board of Directors.
January 9, 2024
·
3 min read
Business
Endologix Appoints Mike Mathias as Chief Commercial Officer
Endologix LLC announced the appointment of Mike Mathias as the company’s Chief Commercial Officer, effective immediately.
March 5, 2024
·
3 min read
Biotech Beach
Endologix to Present at Upcoming LSI US ’24 Emerging Medtech Summit
Endologix LLC today announced that Matt Thompson, President and CEO, will present at the Life Science Intelligence (LSI) USA ’24 Emerging Medtech Summit. Scheduled for March 20, 2024, at 10:55 am PT.
March 14, 2024
·
1 min read
Biotech Beach
Endologix to Present in Two Upcoming Healthcare Conferences
Endologix LLC announced today that the company will be presenting in two upcoming healthcare conferences.
November 9, 2023
·
1 min read
Biotech Beach
Endologix Initiates Percutaneous Transmural Arterial Bypass (PTAB)1 Post-Market Study
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced the initiation of the PTAB1 Post-Market Study.
February 29, 2024
·
3 min read
Business
Endologix Announces that Lucas Buchanan Joins Board of Directors
Endologix LLC is pleased to announce that Lucas Buchanan has been appointed to the Endologix Board of Directors.
August 24, 2023
·
3 min read
Press Releases
Endologix Announces 36-Month Results of DETOUR2 Study at 2024 VIVA Late-Breaking Clinical Trial Session
November 5, 2024
·
5 min read
Policy
Endologix announces the U. S. Centers for Medicare & Medicaid Services granted a Transitional Pass-Through (TPT) Payment for the DETOUR™ System
Endologix LLC announces that the U. S. Centers for Medicare & Medicaid Services granted a Transitional Pass-Through Payment for the DETOUR System, effective January 1, 2024.
December 27, 2023
·
4 min read
1 of 70,484
Next
